Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials

BACKGROUND: The RV144 clinical trial showed for the first time that vaccination could provide modest but significant protection from HIV-1 infection. To understand the protective response, and to improve upon the vaccine's efficacy, it is important to define the structure of the immunogens used...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bin, Morales, Javier F., O'Rourke, Sara M., Tatsuno, Gwen P., Berman, Phillip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425498/
https://www.ncbi.nlm.nih.gov/pubmed/22928048
http://dx.doi.org/10.1371/journal.pone.0043903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425498/
https://www.ncbi.nlm.nih.gov/pubmed/22928048
http://dx.doi.org/10.1371/journal.pone.0043903

Ejemplares similares